|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|
| Total revenues | ||
| Cost of revenue | ||
| Gross profit/(loss) | ||
| Operating expenses | ||
| Selling expenses | ||
| Administrative expenses | ||
| Research and development expenses | ||
| Impairment loss | ||
| Total operating expenses | ||
| Net operating loss | ||
| Non-operating income/(expenses) | ||
| Interest income | ||
| Other income | ||
| Other gains, net | ||
| Interest expenses | ||
| Total non-operating income | ||
| Profit/(loss) before income tax | ||
| Income tax expenses/ (benefits) | ||
| Net income/(loss) | ||
| Less: net income/(loss) attributable to non-controlling interests | ||
| Net income/(loss) attributable to ordinary shareholders | ||
| Other comprehensive income/(loss) | ||
| Foreign currency translation adjustment | ||
| Total comprehensive income/(loss) | ||
| Less: comprehensive income/(loss) attributable to non-controlling interests | ||
| Total comprehensive income/ (loss) attributable to ordinary shareholders | ||
| Net income/(loss) per ordinary share | ||
| Basic (in New Dollars per share and Dollars per share) | ||
| Diluted (in New Dollars per share and Dollars per share) | ||
| Weighted average number of ordinary shares | ||
| Basic (in Shares) | ||
| Diluted (in Shares) |
Loading...
